Drugs / Sutureless Ophthalmic Hydrogel for Corneal Stromal Defects
Sutureless Ophthalmic Hydrogel for Corneal Stromal Defects
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07638215 | May 2026 → Jan 2027 expected | corneal disorder | Suxia Li | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sutureless Ophthalmic Hydrogel for Corneal Stromal Defects | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07638215 ↗ |
| Modality | Other / unclassified | “Injectable hydrogels, as smart materials that transition from a liquid precursor to a solid gel in response to external stimuli (e.g., light, temperature, or chemical...” NCT07638215 ↗ |
| Route | Other | “instilled into the lamellar defect using a sterile syringe” NCT07638215 ↗ |